Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neogen Corporation - Common Stock (NQ:NEOG)

10.35 +0.10 (+0.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neogen Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
3 Russell 2000 Stocks We Keep Off Our Radar
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Neogen (NEOG) Q2 2026 Earnings Call Transcript ↗
Neogen (NEOG) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
5 Insightful Analyst Questions From Neogen’s Q4 Earnings Call
Neogen’s Q4 results were met with a strong positive market reaction, reflecting the company’s return to positive core growth and substantial margin improvement. Management attributed the quarter’s... 
Via StockStory
Topics Earnings
News headline image
3 Inflated Stocks with Warning Signs
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro... 
Via StockStory
News headline image
NEOG Q4 Deep Dive: Operational Improvements and New Leadership Drive Upbeat Outlook
Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue... 
Via StockStory
News headline image
Why Neogen Stock Blasted More Than 31% Higher Today ↗
The company delivered an estimates-trouncing quarter for its shareholders. 
Via The Motley Fool
News headline image
Why Is Neogen (NEOG) Stock Rocketing Higher Today
Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 27.6% in the morning session after the company reported fourth-quarter results that far surpassed Wall Street's expectations and raised its... 
Via StockStory
Topics Artificial Intelligence World Trade
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Neogen Shares Skyrocket as Q2 Earnings Beat Signals Turning Point in 3M Integration Strategy
LANSING, MI – Shares of Neogen Corporation (NASDAQ: NEOG) experienced a dramatic surge in early trading today, climbing nearly 29% after the food and animal safety leader reported second-quarter fiscal... 
Via MarketMinute
Topics Earnings Economy
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
Neogen (NASDAQ:NEOG) Beats Expectations in Strong Q4 CY2025, Stock Jumps 19.8%
Life sciences company Neogen (NASDAQ:NEOG) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 2.8% year on year to $224.7 million. The company’s full-year revenue... 
Via StockStory
News headline image
Neogen Announces Second-Quarter 2026 Results
From Neogen Corporation
Via Business Wire
News headline image
Neogen (NEOG) Q4 Earnings Report Preview: What To Look For
Life sciences company Neogen (NASDAQ:NEOG) will be reporting results this Thursday before the bell. Here’s what to expect. 
Via StockStory
News headline image
Neogen® Announces Two Senior Leadership Appointments
From Neogen Corporation
Via Business Wire
News headline image
1 Healthcare Stock on Our Watchlist and 2 We Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also... 
Via StockStory
Topics Stocks
News headline image
3 Unpopular Stocks with Warning Signs
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
3 Reasons to Sell NEOG and 1 Stock to Buy Instead
Neogen has been on fire lately. In the past six months alone, the company’s stock price has rocketed 52.1%, reaching $7.52 per share. This was partly due to its solid quarterly results, and the... 
Via StockStory
Topics Bankruptcy
News headline image
Neogen Announces Second-Quarter Earnings Release Date
From Neogen Corporation
Via Business Wire
News headline image
Neogen® To Participate in Upcoming Investor Conferences
From Neogen Corporation
Via Business Wire
News headline image
3 Stocks Under $10 We Steer Clear Of
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government... 
Via StockStory
Topics Economy Government
News headline image
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 of Wall Street’s Favorite Stocks Walking a Fine Line
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
Neogen (NASDAQ:NEOG) Q3 Earnings: Leading The Medical Devices & Supplies - Diversified Pack
Let’s dig into the relative performance of Neogen (NASDAQ:NEOG) and its peers as we unravel the now-completed Q3 medical devices & supplies - diversified earnings season. 
Via StockStory
News headline image
Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer
From Neogen Corporation
Via Business Wire
News headline image
3 Russell 2000 Stocks We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Neogen’s Q3 Earnings Call
Neogen’s third quarter results were met with a strong positive market reaction, despite reporting a year-over-year sales decline. Management attributed the quarter’s performance to ongoing operational... 
Via StockStory
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.